BoniPharmex Achieves Nationwide Distribution of FilVel® Products in Sweden
Stockholm, Sweden – BoniPharmex, a joint venture between StartUpPharma Int. AB, a wholly-owned subsidiary of Barnik Invest Group, and DynalisPharma, today announced the successful nationwide distribution of its FilVel® product line across all major pharmacies in Sweden, including Apotek Hjärtat, Apoteket AB, Kronans Apotek, Doz Apotek, Apotea, MEDS Apotek, and Apohem. BoniPharmex has developed a […]
Barnik Invest Launches Cell4Cure AB to Advance Innovative Immunotherapy
Stockholm, Sweden – Barnik Invest Group is pleased to announce the official launch of Cell4Cure AB, a new company focused on developing advanced therapies based on antigen-specific dendritic cell mediated tolerance. This innovative approach aims to treat diseases where the immune system attacks the body’s own tissues. A consortium of former Idogen board members, together […]
BoniPharmex Launches Five New Products in the Swedish Market
Stockholm, Sweden – BoniPharmex, a joint venture between StartUpPharma Int. AB, a wholly-owned subsidiary of Barnik Invest Group, and DynalisPharma, today announced the launch of five new products in the Swedish market. These innovative dietary supplements, collectively known as the FilVel® Solar System, offer a holistic approach to health and well-being. The FilVel® Solar System […]
